https://www.regulations.gov/document/EPA-HQ-OPP-2019-0274-0470

On the basis of the information furnished by you, the subject Experimental Use Permit (EUP) under section 5 of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) is hereby amended and extended for the release of OX5034 Aedes aegypti mosquitoes containing Tetracycline Trans-Activator Variant (tTAV-OX5034) protein and the genetic material (from vector pOX5034) necessary to produce the protein in vivo. The EUP, which is authorized only in the states of Florida and California, will evaluate efficacy of release of adult and eggs of OX5034 Aedes aegypti mosquitoes against wild Aedes aegypti mosquitoes within Monroe County, Florida and Stanislaus, Fresno, Tulare, and San Bernardino counties, California. Shipment and/or use under this permit are subject to the provisions of 40 CFR Part 172.